Table 1.

Anti‐obesity drugs that are currently approved, as of October 2015, by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA)

	Anti‐obesity drug	EMA	FDA
Short‐term use (a few weeks)	Bidiethylpropion	Approved	Approved
	Benzphetamine	Approved	Approved
	Phendimetrazine	Approved	Approved
	Phentermine	Approved	Approved
Long‐term use	Orlistat	Approved	Approved
	Lorcaserin	Not approved	Approved
	Phentermine/extended‐release topiramate	Not approved	Approved
	Naltrexone/bupropion	Approved	Approved
	Liraglutide	Approved	Approved